Neomer Licensing Opportunities
Find out if Neomer Licensing is for you. Do you:
Not have the budget for a full custom aptamer project?
Have lab space and personnel to do an aptamer selection yourself?
Have targets that cannot be shipped to a lab for a custom aptamer project?
If you answered yes to any of these, Neomer Licensing may be for you!
The Neomer Selection Method
Neomer method involves the use of a library of the same 4.29 billion sequences for every selection. We can characterize the level of binding of a target molecule on all 4.29 billion sequences in a single selection round, followed by a clever trick we employ for NGS analysis. We are able to ensure that any sequence that binds to these proteins even weakly is removed as a candidate for your target molecule.
This means that now we can:
- Identify aptamers that bind to the same epitope across proteins
- Identify aptamers that distinguish between different isoforms of a protein
- Coupled with our proprietary FRELEX platform, Neomers enables the definitive identification of soluble metabolites.
Licensing Models
Includes:
- – Neomer library for one selection
- – Frequency analysis of Next-Generation Sequencing results
- – Meta-analysis of structures
- – Candidate sequence selection
Selection, Next-Generation Sequencing, and preparation done by you
Exclusive, non-royalty bearing, global, irrevocable license to the commercial use of the aptamers that we select you. This is the same agreement that we off for our full custom aptamer projects.
Includes:
- – Neomer library for one selection
- – Next-Generation Sequencing preparation
- – Next-Generation Sequencing
- – Frequency analysis of Next-Generation Sequencing results
- – Meta-analysis of structures
- – Candidate sequence selection
Only selection done by you.
Exclusive, non-royalty bearing, global, irrevocable license to the commercial use of the aptamers that we select you. This is the same agreement that we off for our full custom aptamer projects.
